Patient-elected low-dose intravenous naloxone for rapid buprenorphine induction: a case report
Abstract Background Buprenorphine is a common partial opioid agonist treatment for opioid use disorder (OUD). Despite its efficacy, major challenges to induction include the significant time consumption and the difficult requirement for patients to be in moderate opioid withdrawal. Case presentation...
Saved in:
| Main Authors: | Pouya Azar, Jessica Machado, Jane J. Kim, James S. H. Wong, Mohammadali Nikoo, Victor W. Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Addiction Science & Clinical Practice |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13722-025-00572-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
by: Minna M. Kanervo, et al.
Published: (2023-03-01) -
Patients' perspectives on buprenorphine subcutaneous implant: a case series
by: Claudio Pierlorenzi, et al.
Published: (2024-04-01) -
Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination
by: Winter Roth, PharmD, BCPP, et al.
Published: (2025-04-01) -
An Indigenous-led buprenorphine-naloxone treatment program to address opioid use in remote Northern Canada
by: Aleksandra M. Zuk, et al.
Published: (2024-12-01) -
Buprenorphine/naloxone initiation in the emergency department: A series of vignettes
by: Margarita Popova, et al.
Published: (2024-12-01)